Stockholders’ Equity and Equity Incentive Plans (Tables)

3 Months Ended

Apr. 30, 2023

Stockholders' Equity Note [Abstract]

Schedule of Stock Option Activity Under Equity Incentive Plan

A summary of stock option activity under our equity incentive plan and related information is as follows:

	Stock Options
	Outstanding Stock Options	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value
	(in thousands, except share, life, and per share data)
Balance as of January 31, 2023	4,800,616	$	8.22	4.9	$	322,929
Exercised	(501,968)	$	8.50		$	30,864
Canceled/forfeited/expired	(250)	$	58.18
Outstanding as of April 30, 2023	4,298,398	$	8.19	4.5	$	232,898
Vested and expected to vest as of April 30, 2023	4,298,398	$	8.19	4.5	$	232,898
Exercisable as of April 30, 2023	4,294,422	$	8.12	4.5	$	232,887

Schedule of Restricted Stock Units (RSUs) Activity Under Equity Incentive Plan

A summary of restricted stock unit (“RSU”) activity under our equity incentive plan and related information is as follows:

	RSUs
	RSUs	Weighted- Average Grant Date Fair Value Per Share
Unvested as of January 31, 2023	21,868,533	$	109.31
Granted	7,565,078	$	69.89
Vested	(3,130,859)	$	112.03
Canceled/forfeited	(2,277,349)	$	108.80
Unvested as of April 30, 2023	24,025,403	$	96.60

Schedule of Stock-based Compensation Expense by Line Item

The stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows:

	Three Months Ended April 30,
	2023		2022
	(in thousands)
Cost of revenue	$	38,089	$	31,150
Research and development	81,466		55,751
Sales and marketing	112,593		93,795
General and administrative	50,197		28,667
Total stock-based compensation expense	$	282,345	$	209,363
Benefit from income taxes	(49,677)		(42,915)
Total stock-based compensation expense recorded to net income	$	232,668	$	166,448